Abstract 748: The glucose metabolism targeting therapies and withaferin A eliminate epidermal growth factor tyrosine kinase inhibitor-induced drug-tolerant persisters in non-small lung cancer cells

Cancer Cells ◽

Kinase Inhibitor ◽

Withaferin A ◽

Identification of Clinically Approved Drugs Indacaterol and Canagliflozin for Repurposing to Treat Epidermal Growth Factor Tyrosine Kinase Inhibitor-Resistant Lung Cancer

Frontiers in Oncology ◽

10.3389/fonc.2017.00288 ◽

2017 ◽

Vol 7 ◽

Cited By ~ 2

Author(s):

Hongjian Li ◽

Christy Wing-Sum Tong ◽

Yee Leung ◽

Man-Hon Wong ◽

Kenneth Kin-Wah To ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Epidermal Growth ◽

Approved Drugs

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor

10.32388/jfobd7 ◽

2020 ◽

Author(s):

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Receptor Tyrosine Kinase Inhibitor ◽

Association between E-cadherin and sensitivity of hepatocellular carcinoma to treatment with epidermal growth factor receptor tyrosine kinase inhibitor

Academic Journal of Second Military Medical University ◽

10.3724/sp.j.1008.2014.00915 ◽

2014 ◽

Vol 35 (8) ◽

pp. 915

Author(s):

Rong-chun XING ◽

Jun ZHENG ◽

Ping CHEN ◽

Wei-hong ZHENG ◽

Wei LIU ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Osteopontin improves sensitivity to tyrosine kinase inhibitor in lung adenocarcinoma in vitro by promoting epidermal growth factor receptor phosphorylation

Journal of Cancer Research and Clinical Oncology ◽

10.1007/s00432-021-03731-2 ◽

2021 ◽

Author(s):

Yu-Jin Wang ◽

Qing-Wen Wang ◽

Dong-Hu Yu ◽

Cong-Kuan Song ◽

Zi-Xin Guo ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Lung Adenocarcinoma ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Glucose metabolism-targeted therapy and withaferin A are effective for epidermal growth factor receptor tyrosine kinase inhibitor-induced drug-tolerant persisters

Cancer Science ◽

10.1111/cas.13266 ◽

2017 ◽

Vol 108 (7) ◽

pp. 1368-1377 ◽

Cited By ~ 4

Author(s):

Kei Kunimasa ◽

Tatsuya Nagano ◽

Yohei Shimono ◽

Ryota Dokuni ◽

Tatsunori Kiriu ◽

...

Keyword(s):

Targeted Therapy ◽

Growth Factor ◽

Glucose Metabolism ◽

Epidermal Growth Factor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Withaferin A ◽

A report of two bronchioloalveolar carcinoma cases which were rapidly improved by treatment with the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 ("Iressa"1

Cancer Science ◽

10.1111/j.1349-7006.2003.tb01464.x ◽

2003 ◽

Vol 94 (5) ◽

pp. 453-458 ◽

Cited By ~ 36

Author(s):

Seiji Yano ◽

Takanori Kanematsu ◽

Toyokazu Miki ◽

Yoshinori Aono ◽

Masahiko Azuma ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Bronchioloalveolar Carcinoma ◽

Pharmacological characterization of MP-412 (AV-412), a dual epidermal growth factor receptor and ErbB2 tyrosine kinase inhibitor

Cancer Science ◽

10.1111/j.1349-7006.2007.00613.x ◽

2007 ◽

Vol 98 (12) ◽

pp. 1977-1984 ◽

Cited By ~ 22

Author(s):

Tsuyoshi Suzuki ◽

Akihiro Fujii ◽

Junichi Ohya ◽

Yusaku Amano ◽

Yasunori Kitano ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Pharmacological Characterization ◽

First Reported Case of Unexpected Response to an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in the I744M Uncommon EGFR Mutation

Clinical Lung Cancer ◽

10.1016/j.cllc.2015.06.002 ◽

2015 ◽

Vol 16 (6) ◽

pp. e259-e261 ◽

Cited By ~ 4

Author(s):

Emmanuelle Kempf ◽

Ludovic Lacroix ◽

Jean-Charles Soria

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Egfr Mutation ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

N-Glycan fucosylation of epidermal growth factor receptor modulates receptor activity and sensitivity to epidermal growth factor receptor tyrosine kinase inhibitor

Cancer Science ◽

10.1111/j.1349-7006.2008.00847.x ◽

2008 ◽

Vol 99 (8) ◽

pp. 1611-1617 ◽

Cited By ~ 44

Author(s):

Kazuko Matsumoto ◽

Hideyuki Yokote ◽

Tokuzo Arao ◽

Mari Maegawa ◽

Kaoru Tanaka ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Receptor Activity ◽

Paronychia Induced by Gefitinib, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor

The Journal of Dermatology ◽

10.1111/j.1346-8138.2003.tb00387.x ◽

2003 ◽

Vol 30 (3) ◽

pp. 261-262 ◽

Cited By ~ 27

Author(s):

Junji Nakano ◽

Mitsutaka Nakamura

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Receptor Tyrosine Kinase Inhibitor ◽